ATIVAN INJECTION LIQ 4MG/ML
ATIVAN INJECTION LIQ 4MG/ML
Discontinued
DIN Number
02041405
Drug Class
Human
Market Date
Dec 31, 1994
Company
HC
wyeth canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02041405
AIG Number0110731004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA06 LORAZEPAM
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
,
Intravenous
AHFS Classification28:24.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
LORAZEPAMActive
Strength: 4 MG / ML
Monograph: LORAZEPAM